203 related articles for article (PubMed ID: 33719171)
1. A potential contribution of decreased serum galectin-10 levels to systemic inflammation and pulmonary vascular involvement in systemic sclerosis.
Awaji K; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Norimatsu Y; Ikawa T; Watanabe Y; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2021 Jul; 30(7):959-965. PubMed ID: 33719171
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in
Cunha EGC; de Lima CAD; Vilar KM; Nóbrega MF; Almeida AR; Pereira MC; Dantas AT; Gonçalves RSG; Rêgo MJBM; Duarte ALBP; Pitta MGDR
Autoimmunity; 2021 Jun; 54(4):187-194. PubMed ID: 33973825
[TBL] [Abstract][Full Text] [Related]
4. A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis.
Saigusa R; Yamashita T; Miura S; Hirabayashi M; Nakamura K; Miyagawa T; Fukui Y; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2019 May; 28(5):536-542. PubMed ID: 30739341
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1 and Galectin-3 Expression in Lesional Skin of Patients With Systemic Sclerosis-Association With Disease Severity.
Mora GF; Zubieta MR
J Clin Rheumatol; 2021 Dec; 27(8):317-323. PubMed ID: 32501939
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
[TBL] [Abstract][Full Text] [Related]
7. Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment.
Sundblad V; Gomez RA; Stupirski JC; Hockl PF; Pino MS; Laborde H; Rabinovich GA
Front Pharmacol; 2021; 12():650605. PubMed ID: 33959016
[TBL] [Abstract][Full Text] [Related]
8. Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis.
Ikawa T; Miyagawa T; Fukui Y; Minatsuki S; Maki H; Inaba T; Hatano M; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
Int J Rheum Dis; 2021 May; 24(5):711-718. PubMed ID: 33750014
[TBL] [Abstract][Full Text] [Related]
9. Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis.
Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
J Dermatol; 2015 May; 42(5):461-6. PubMed ID: 25766303
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
[TBL] [Abstract][Full Text] [Related]
11. Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosis.
Masui Y; Asano Y; Akamata K; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Rheumatol Int; 2014 Aug; 34(8):1165-70. PubMed ID: 24141536
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis.
Chihara M; Kurita M; Yoshihara Y; Asahina A; Yanaba K
J Immunol Res; 2018; 2018():9473243. PubMed ID: 30599005
[TBL] [Abstract][Full Text] [Related]
13. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
[TBL] [Abstract][Full Text] [Related]
14. Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.
Miyagawa T; Taniguchi T; Saigusa R; Fukayama M; Takahashi T; Yamashita T; Hirabayashi M; Miura S; Nakamura K; Yoshizaki A; Sato S; Asano Y
Rheumatology (Oxford); 2020 Aug; 59(8):2005-2015. PubMed ID: 31782787
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
[TBL] [Abstract][Full Text] [Related]
16. Serum level of circulating syndecan-1: A possible association with proliferative vasculopathy in systemic sclerosis.
Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
J Dermatol; 2016 Jan; 43(1):63-6. PubMed ID: 26076711
[TBL] [Abstract][Full Text] [Related]
17. Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre study.
Vadasz Z; Balbir Gurman A; Meroni P; Farge D; Levi Y; Ingegnoli F; Braun-Moscovici Y; Rosner I; Slobodin G; Rozenbaum M; Jiries N; Kaly L; Boulman N; Zilber K; Ginsberg S; Awisat A; Goldberg Y; Lurie M; Ghigna MR; Guignabert C; Humbert M; Rimar D
Rheumatology (Oxford); 2019 Sep; 58(9):1547-1555. PubMed ID: 30770717
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis.
Yazawa N; Kikuchi K; Ihn H; Fujimoto M; Kubo M; Tamaki T; Tamaki K
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):70-5. PubMed ID: 10607322
[TBL] [Abstract][Full Text] [Related]
19. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.
Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ
Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823
[TBL] [Abstract][Full Text] [Related]
20. Serum vasohibin-1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis.
Fukui Y; Nakamura K; Hirabayashi M; Miyagawa T; Toyama S; Omatsu J; Awaji K; Ikawa T; Norimatsu Y; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2021 Jul; 30(7):951-958. PubMed ID: 33682189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
